Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
May 10, 2016 $30.93 $31.67 $30.25 $31.59 312 920
May 09, 2016 $29.36 $31.22 $29.36 $30.80 254 651
May 06, 2016 $30.28 $30.88 $27.01 $29.43 916 804
May 05, 2016 $28.59 $31.94 $28.59 $30.19 880 026
May 04, 2016 $28.12 $28.33 $26.72 $27.50 456 846
May 03, 2016 $29.95 $30.35 $28.23 $28.33 387 609
May 02, 2016 $30.05 $30.46 $28.53 $30.33 364 314
Apr 29, 2016 $29.93 $30.21 $29.13 $29.95 310 050
Apr 28, 2016 $30.36 $31.66 $29.76 $30.11 215 835
Apr 27, 2016 $31.34 $31.66 $30.30 $30.70 274 534
Apr 26, 2016 $31.35 $31.86 $30.32 $31.03 255 001
Apr 25, 2016 $32.28 $33.70 $31.14 $31.45 456 134
Apr 22, 2016 $31.66 $32.48 $30.90 $32.20 168 192
Apr 21, 2016 $30.28 $31.76 $30.01 $31.68 300 863
Apr 20, 2016 $29.93 $31.08 $29.25 $30.44 611 250
Apr 19, 2016 $31.48 $31.48 $28.84 $29.18 316 352
Apr 18, 2016 $31.12 $31.60 $30.13 $31.47 269 965
Apr 15, 2016 $31.29 $31.60 $30.15 $31.23 167 894
Apr 14, 2016 $31.69 $32.35 $30.88 $31.44 169 012
Apr 13, 2016 $31.89 $31.92 $30.39 $31.72 205 339
Apr 12, 2016 $30.62 $31.53 $28.97 $31.42 319 643
Apr 11, 2016 $31.46 $32.45 $30.25 $30.48 312 925
Apr 08, 2016 $32.19 $32.54 $30.88 $31.26 473 218
Apr 07, 2016 $31.36 $32.38 $30.02 $31.45 525 084
Apr 06, 2016 $29.96 $32.00 $29.76 $31.92 498 057
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT